000			01593 a2200421 4500
005			20250516190252.0
264		0	_c20140922
008			201409s 0 0 eng d
022			_a1878-1705
024	7		_a10.1016/j.intimp.2013.12.012 _2doi
040			_aNLM _beng _cNLM
100	1		_aMelo, L M
245	0	0	_aEffects of P-MAPA immunomodulator on Toll-like receptor 2, ROS, nitric oxide, MAPKp38 and IKK in PBMC and macrophages from dogs with visceral leishmaniasis. _h[electronic resource]
260			_bInternational immunopharmacology _cFeb 2014
300			_a373-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aDog Diseases _ximmunology
650	0	4	_aDogs
650	0	4	_aFemale
650	0	4	_aImmunologic Factors _xpharmacology
650	0	4	_aKruppel-Like Transcription Factors _ximmunology
650	0	4	_aLeishmaniasis, Visceral _ximmunology
650	0	4	_aLeukocytes, Mononuclear _xdrug effects
650	0	4	_aMacrophages _xdrug effects
650	0	4	_aMale
650	0	4	_aNitric Oxide _ximmunology
650	0	4	_aReactive Oxygen Species _ximmunology
650	0	4	_aToll-Like Receptor 2 _ximmunology
650	0	4	_ap38 Mitogen-Activated Protein Kinases _ximmunology
700	1		_aPerosso, J
700	1		_aAlmeida, B F M
700	1		_aSilva, K L O
700	1		_aSomenzari, M A
700	1		_ade Lima, V M F
773	0		_tInternational immunopharmacology _gvol. 18 _gno. 2 _gp. 373-8
856	4	0	_uhttps://doi.org/10.1016/j.intimp.2013.12.012 _zAvailable from publisher's website
999			_c23401283 _d23401283